Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: caspofungin acetate

« Back to Dashboard

Caspofungin acetate is the generic ingredient in one branded drug marketed by Merck and is included in one NDA. There are five patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for caspofungin acetate. One supplier is listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: caspofungin acetate

Tradenames:1
Patents:5
Applicants:1
NDAs:1
Drug Master File Entries: see list5
Suppliers: see list1
Therapeutic Class:Antifungals

Pharmacology for Ingredient: caspofungin acetate

Ingredient-typeLipopeptides
Drug ClassEchinocandin Antifungal

Tentative approvals for CASPOFUNGIN ACETATE

Applicant Application No. Form Dosage
<disabled><disabled>INJECTABLE; INJECTION70MG/VIAL
<disabled><disabled>INJECTABLE; INJECTION50MG/VIAL

Clinical Trials for: caspofungin acetate

Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis
Status: Completed Condition: Invasive Aspergillosis

Open, Pharmacokinetic Study of Caspofungin Acetate in Immunocompromised Young Children With Febrile Neutropenia (0991-042)
Status: Completed Condition: Fungal Infection

Pharmacokinetics of Caspofungin (Cancidas ®) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variates
Status: Completed Condition: Invasive Fungal Infection

Pharmacokinetic, Safety and Efficacy of Intermittent Application of Caspofungin for Antifungal Prophylaxis
Status: Completed Condition: Fungal Infection

Pharmacokinetics of Caspofungin in Burn Patients
Status: Completed Condition: Thermal Injury

Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067)
Status: Terminated Condition: Invasive Candidiasis

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck
CANCIDAS
caspofungin acetate
INJECTABLE;IV (INFUSION)021227Jan 26, 2001RXYes5,952,300*PED<disabled>Y<disabled>
Merck
CANCIDAS
caspofungin acetate
INJECTABLE;IV (INFUSION)021227Jan 26, 2001RXYes6,136,783*PED<disabled>Y<disabled>
Merck
CANCIDAS
caspofungin acetate
INJECTABLE;IV (INFUSION)021227Jan 26, 2001RXYes5,792,746*PED<disabled><disabled>
Merck
CANCIDAS
caspofungin acetate
INJECTABLE;IV (INFUSION)021227Jan 26, 2001RXYes5,378,804*PED<disabled><disabled>
Merck
CANCIDAS
caspofungin acetate
INJECTABLE;IV (INFUSION)021227Jan 26, 2001RXYes5,514,650*PED<disabled>Y<disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc